By |

Profile

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

Contact Information

Website: www.eyenovialab.com
Email: admin@eyenoviabio.com
Main Phone: +1 917 289-1117
Address: 501 Fifth Avenue
Address 2: Suite 1404
State: NY
City / Town: New York
Country: USA
Postal Code: 10017

Issuer Information

Exchange: NSC
CEO: Tsontcho Ianchulev
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

Contact Information

Website: www.eyenovialab.com
Email: admin@eyenoviabio.com
Main Phone: +1 917 289-1117
Address: 501 Fifth Avenue
Address 2: Suite 1404
State: NY
City / Town: New York
Country: USA
Postal Code: 10017

Issuer Information

Exchange: NSC
CEO: Tsontcho Ianchulev
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.76 $ 0.09 (1.93%)
Last Price 4.76 Change $ 0.09 Change % 1.93 Tick N/A
Bid 4.50 Bid Size 1,500.00 Ask 5.62 Ask Size 1,000.00
Open 4.83 High 5.03 Low 4.57 Prev Close 4.67
Last Trade Volume 233,324 52 Wk Hi 10.20 52 Wk Low 2.40
Market Cap 53.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,288,996.00 EPS (TTM) -1.21 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 16
Number of Buys 4 16
Number of Sells 0 0
Net Activity 453686 515616
Last 10 Buys Shares
Michael M Rowe 1,000
Michael M Rowe 1,000
Charles E. Mather 1,000
Charles E. Mather 1,000
Tsontcho Ianchulev 1,000
John P. Gandolfo 1,000
Tsontcho Ianchulev 1,000
Fredric N. Eshelman 1,000
Curt LaBelle 1,000
Shuhei Yoshida 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 35 35 35 35
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 20.67 20.67 20.67 20.67
Standard Deviation 12.5 12.5 12.5 12.5
Date of Most Recent Estimate 01/16/19 11/29/18 11/29/18 01/16/19
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1